CRH delivered strong half-year figures which beat consensus expectations, achieving a 90bp EBITDA margin increase, and presenting a positive outlook for FY23. Sales and EBITDA were up 8% yoy and 14% yoy, respectively, mainly supported by a consistent price increase and operational efficiency that was able to offset inflation and unfavourable weather conditions. The company also continued its share buy-back programme amounting to $1bn in H1, together with an interim dividend increase proposal o ....